FDA Investigator Ephrem Hunde, PhD

Ephrem Hunde, PhD has conducted inspections on 10 sites in 6 countries as of 25 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
10
Last Inspection Date:
25 Mar 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
100006825
Countries of Inspections:
United States of America, Belgium, China, Denmark, Ireland, Italy
FDA Investigators that have inspected at least one site in common with Ephrem Hunde, PhD:
Adam R Cooke, Alice S Tsao, Alifiya H Ghadiali, Anita Narula, PhD, Annet R Rajan, Anthony F Lorenzo, Anthony W Lee, Ariel Cruz Figueroa, Azza Talaat, Bill Tacket, Jr, Bo Chi, PhD, Brandon C Heitmeier, Brian M Janelsins, PhD, Brooke K Higgins, Brooke K Seeman, Bruce H Mccullough, Carol L Rehkopf, Carole L Jones, Charisse K Green, Christopher Downey, PhD, Christopher R Czajka, Christopher S Keating, Christopher T Middendorf, Daniel Lagasse, David J Eide, Deborah Schmiel, PhD, Dennis Cantellops Paite, Derek S Smith, PhD, Diane L Raccasi, Diane T Bargo, Diane T O'brien, Dogbeda F Mackenzie, Dongping Dai, PhD, Douglas A Campbell, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Emest F Bizjak, Esther C Broner, PhD, Francis A Guidry, Gene D Arcy, Gerald B Seaborn, Jr, Gregory Price, Hamet M Toure, PharmD MPH, Hongna Wang, Jacqueline Mdiaz Albertini, James W Leonette, Janet A Rajan, Jeanne Fringer, PhD, Jeffrey M Watson, Jeffrey P Raimondi, Jessica Hankins, PhD, Joey V Quitania, Jonathan W Chapman, José E Meléndez, Justin A Boyd, Kara D Dobbin, Katherine Szestypalow, Kathleen M Jordan, Kelly L Anderson, Kenneth Nieves, Kristin M Abaonza, Lance Mde Souza, MBA, Latorie S Jones, LCDR Debra Emerson, Lori S Lawless, Madushini Dharmasena, PhD, Malgorzata G Norton, PhD, Marcus F Yambot, Maria Cruz Fisher, Marion Michaelis, Melissa J Garcia, Merideth K Rose, Michael J Vardon, Michael Shanks, MS, Michelle Yclark Stuart, Monica Commerford, PhD, Mra Davism, Mra Mcculloughj, Mra V Millarw, Nancy A Bellamy, Nebil A Oumer, Nicholas A Violand, Nicholas L Hunt, Nicole K Trudel, Parul M Patel, Patsy J Domingo, Peter E Baker, Prabhu P Raju, Prajakta A Varadkar, Pratik S Upadhyay, DDC, Qin Xu, Quyen T Tran, Rachel C Harrington, Rachel Novak, PhD, Rashmi Rawat, PhD, Reba A Gates, Rebecca Rodriguez, Regina Gibson Melton, Regina T Brown, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Robert D Tollefsen, Robert J Martin, Rodney G Raiford, Roger F Zabinski, Rose Xu, Sara H Gabel, Sena G Dissmeyer, Seneca D Toms, Simone E Pitts, Song Y Lavalais, Sonya M Edmonds, Steven P Donald, Tekalign Wondimu, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy T Kapsala, Toyin B Oladimeji, Tracey L Harris, Tracy Denison, PhD, Uduak M Inokon, Veronica Fuentes, MS, Viviana Matta, Walter L Fava, Wayne E Seifert, Wendy G Tan, PhD, William A Warnick, William H Linkroum, William V Millar, Xianghong Jing (Emily), PhD, Xiaokuang Lai, PhD, Yasamin Ameri, Yehualashet A Gessesse, Zhong Li, PhD

Ephrem Hunde, PhD's Documents

Publish Date Document Type Title
May, 2018 FDA 483 Response Biogen U.S. Corporation - Form 483R, 2018-05-21
September, 2018 FDA 483 BSP Pharmaceuticals SpA - Form 483, 2018-09-21
April, 2017 FDA 483 Boehringer Ingelheim Fremont, Inc. - Form 483, 2017-04-04
July, 2016 FDA 483 FUJIFILM Diosynth Biotechnologies Denmark ApS - Form 483, 2016-07-08
May, 2018 EIR Biogen U.S. Corporation - EIR, 2018-05-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more